The Micro-Infusion Disclosure Ledger
A standing reference, re-read monthly, dated per cell
The Micro-Infusion Disclosure Ledger: What Ten Brands Publish, and What They Do Not
Marketing in this category is interchangeable; disclosure is not. This ledger records, for ten at-home micro-infusion kits, the facts each brand publishes on its own pages and the facts it leaves out: needle length, sterilisation method, how the serum reaches the needles, ingredient lists, PDRN source, guarantees, and whether an identifiable company stands behind the product. Every cell carries the date it was read.
How to read this ledger
EvenSkyn publishes its own entry in full rather than summarising it. The batch certificates of analysis, the PDRN raw-material characterisation including its measured molecular weight, the complete INCI declaration and the supplier source declarations behind the Syntha-Pep serum are set out in the Syntha-Pep Transparency Lab.
Each cell states what a brand's own page said on the date in brackets. Three kinds of entry appear. A stated fact is quoted or summarized with its date. "Not published" means we looked on that date and the information was absent from the pages read. "Not recorded in our reads" means the gap is ours, not necessarily the brand's: we have not yet checked that cell, and it will not be scored against anyone. Where a figure has changed between reads, both the current and the earlier figure are kept, because the change itself is information.
The ledger
Table 1. Ten brands, nine disclosure dimensions, each cell dated to the day it was read.
| Brand | Needle length as stated | Sterilisation method named | Serum path | Ingredient list | PDRN and source | Money-back guarantee | Identifiable company | Review count shown | Claims language on the page |
|---|---|---|---|---|---|---|---|---|---|
| Alqemi | 0.5 mm (7 Nov 2026) | No method named; single-use needle heads described as sterile (7 Nov 2026) | Pour: serum is poured into the device bottle (7 Nov 2026) | Published (7 Nov 2026) | Yes; salmon-derived, stated; the serum page lists 562,400 PPM (7 Nov 2026) | 30 days on the serum page; refund minus a 15% restocking fee, or full store credit (7 Nov 2026) | Platinum Skin Care, with a New Baltimore, Michigan street address; no registration number (7 Nov 2026) | Not recorded in our reads | EXO-PDRN product naming and "Injection-Grade" wording on the serum page; the kit page disputes the category's thinner-than-a-human-hair needle wording, giving root diameters instead; the serum page also reads "backed by 600+ clinical studies" and "Clinically proven" (7 Nov 2026) |
| AMIRO | 0.5 mm (7 Nov 2026) | No method named; cartridges described as sterile and single-use (7 Nov 2026) | Pour: solution is poured into the microsphere bottle (7 Nov 2026) | Published (30 Aug 2026); the page names key actives with percentages (7 Nov 2026) | Yes; the FAQ titles PDRN as Salmon DNA while its answer says only purified DNA fragments (7 Nov 2026); stated salmon-derived on 31 Aug 2026; 27% describes a freeze-dried microsphere before reconstitution (7 Nov 2026) | 90 days; 1-year device warranty (7 Nov 2026) | Terms name AMIRO (HK) LIMITED as the operator, governed by the laws of Hong Kong; no street address or registration number found (7 Nov 2026). On 2 Oct 2026 the terms named only "Amiro Official Store" as the operator, governed by the laws of China | "Based on 11 reviews" (7 Nov 2026); "Based on 8 reviews" on 2 Oct 2026; 6, all five-star, on 31 Aug 2026 | "Recommended by Dr. Charles S. Lee | Board Certified Dermatologist", while an image description on the same page calls him a plastic surgeon (7 Nov 2026; the line was also read on 31 Aug and 2 Oct 2026). A tile labeled a companion serum "FDA Approved" on 31 Aug and 2 Oct 2026; it did not appear in our 23 Sep or 7 Nov 2026 text reads |
| Dr. Pen MIS20 | 0.25 mm (7 Nov 2026) | No method named; stamp heads described as single-use sterile (7 Nov 2026) | Direct ampoule insertion, contrasted on the page with pouring serum into a separate container (7 Nov 2026) | Published in full for both ampoules and the mask sheet, in a collapsed section of the page (7 Nov 2026) | Yes; Sodium DNA (PDRN) named in the anti-aging ampoule copy and its ingredient list; source not stated (7 Nov 2026) | No money-back guarantee found on the product page; a 1-year warranty is stated (7 Nov 2026) | eShopping Group Pty Ltd, trading as Dr. Pen Australia, ABN 23 606 860 806, named in the terms of service (7 Nov 2026); a Welshpool, Western Australia address was recorded on 13 Aug 2026; the only registration number in this ledger | Not recorded in our reads | "Used in salons" and "Trusted by professionals"; a disclaimer that the product may not have been evaluated by the TGA or FDA (7 Nov 2026) |
| Elixa | Not published (7 Nov 2026) | No method named; needle heads described as sterile (7 Nov 2026) | The page describes both paths: pouring the serum into the device chamber in one guide, and attaching the needle head directly onto the serum bottle in another (7 Nov 2026; also read on 2 Oct and 23 Sep 2026); read as pour only on 2 Sep 2026 and as a sealed pre-filled vial on 23 Aug 2026 | Published (7 Nov 2026) | Yes; salmon-derived, stated (7 Nov 2026) | 90-day returns, "if you're not completely happy" (7 Nov 2026) | The terms name "ELIXA Skincare" with a 5 Delhi Road, Sydney NSW 2113 address and an email contact; no legal-form suffix or registration number found (7 Nov 2026) | A "4.8 (571 Reviews)" header badge, "Rated 'Excellent' by 12,000+ Happy Customers" and "4.7 / 5 from 440 reviews" in the reviews section (7 Nov 2026); the reviews section read "4.7 / 5 from 411 reviews" on 2 Oct 2026 and "4.8 / 5 from 393 reviews" on 2 Sep 2026 | "Dermatologist Reviewed & Approved", with no dermatologist named in the page text; "Clinical-Grade Results in 6 Treatments or Less"; "Your skin absorbs ingredients up to 3x better after infusion" (7 Nov 2026). The "Recommended by Dr. Marie Laurent | Board Certified Dermatologist" line and a footnoted 8-week consumer study of 42 participants, read on 2 Oct 2026 (the study first on 2 Sep 2026), did not appear in our 7 Nov 2026 text read |
| EvenSkyn MicroInfuser | 0.5 mm nominal, fixed at the head (7 Nov 2026) | Gamma, stated on the product page (7 Nov 2026) | Sealed single-use ampoule clicks onto the head; nothing is poured (7 Nov 2026) | Published in full, collagen entries included (7 Nov 2026) | Yes; biosynthetic and not derived from salmon, per supplier documentation reviewed in August 2026; the product page states the same and declares PDRN at 0.2% (7 Nov 2026). Every other kit in this ledger that states a PDRN source states salmon | 60 days from delivery, on unused treatments, for US and Canada residents: each kit counts as four treatments and the unused ones are refunded, and the buyer pays return shipping; full terms are in our returns policy (7 Nov 2026). The product page now says the kit has no warranty, and that a head or ampoule arriving damaged is replaced if reported within 14 days of delivery (7 Nov 2026); on 12 Oct 2026 it stated a 12-month device warranty and a refund of 25% of the kit price for each sealed treatment returned | Our public terms name EvenSkyn, and the site footer reads "EVENSKYN® Limited"; no registration number is given: the weakest entry in our own row (7 Nov 2026) | 4.9 out of 5 from 16 reviews on the product page (7 Nov 2026); no reviews were shown on 2 Oct 2026 | Certification badges for GMP, sensitive skin and cruelty-free, and a Clinicians' Choice badge from FrontrowMD described as 100+ clinicians sharing the product without compensation (2 Sep 2026; these are image or embedded elements our text reads cannot see, and FrontrowMD frames were present on the product page on 7 Nov 2026); the product details read "cleanroom serum fill under Good Manufacturing Practice, ISO-certified facility" and "cosmetic device, not a medical device and not FDA-cleared" (7 Nov 2026); an internal study is described as unpublished and participant-blinded, with no results quoted (7 Nov 2026; first recorded on 21 Oct 2026); no original, number-one or clinically proven claims in the product page text (7 Nov 2026) or the homepage text (2 Oct 2026) |
| Glamory MicroLift | 0.5 mm (7 Nov 2026) | Vials described as "pre-sterilized" in the FAQ; no method named. The same page says the system is "designed for single use only" with the roller discarded after one application, and elsewhere says to replace the roller head after 6 to 8 uses (7 Nov 2026; also read on 2 Oct 2026). Our 23 Sep 2026 read found no sterile wording and recorded only the 6 to 8 uses instruction; vials were also described as pre-sterilized on 2 Sep 2026 | Sealed vial; break the seal, remove the stopper and twist on the head, described as feeding a roller rather than a stamp (7 Nov 2026; also read on 2 Oct and 23 Sep 2026) | Six featured ingredients are named; no full INCI list found in our read (7 Nov 2026) | None (7 Nov 2026) | 30 days (7 Nov 2026) | TryGlamory LLC, named in the terms as owner and maintainer of the website, with a 30 N. Gould Street, Sheridan, Wyoming address given for its legal department and copyright agent; no registration number found (7 Nov 2026); the brand's FAQ also gives a Tucson, Arizona address, with no company name beside it (7 Nov 2026) | 4.8, "Based on 15,356 Users", unchanged in every read since August 2026 (7 Nov 2026) | "Dermatologist Approved", with no named source; "Increases serum absorption by 300%" (7 Nov 2026) |
| Glov | 0.25 mm on the main product page (7 Nov 2026); two pages stated 0.5 mm in July 2026 | No method named; needles described as sterilized (7 Nov 2026) | User-filled chamber (7 Nov 2026) | Published (7 Nov 2026) | None (7 Nov 2026) | 30 days (7 Nov 2026) | Glov Beauty LLC, named in the terms of service as the site operator, with a 7951 Nookfield Dr, Las Vegas, Nevada address and Nevada governing law (7 Nov 2026); the returns and refund policies name only "Glov Beauty", with a return address in Fieldsboro, New Jersey, and the product page FAQ still gives a 570 Solon Road, Bedford, Ohio address (7 Nov 2026). On 2 Oct 2026 the returns and exchange policy named Glov Beauty LLC with the Bedford address; "Glov Beauty LLC" was recorded as named in two policies on 28 Jul 2026 | Two figures on one page: "23.750+ reviews" and "9,148 Reviews" (7 Nov 2026) | Markets the system as suitable around eyes, lips and neck; "Increases serum absorption by 300%"; the FAQ claims it reaches the deep dermal layer; "60+ Board-Certified Dermatologists and licensed estheticians recommend Glov Beauty" (7 Nov 2026) |
| Qure | 0.5 mm (7 Nov 2026) | Ethylene oxide (EO): the landing page now says every needle head is "EO-sterilized, single-use, and disposable", and a bundle product page states "EO-sterilized (ethylene oxide)" (7 Nov 2026); on 2 Oct 2026 the landing page named no method | Twist off the serum vial cap and screw on the sterile needle head, per the how-to steps (7 Nov 2026); read as pouring an ampoule into the device chamber on 28 Jul 2026 | Full ingredient lists published for both serums, with a page note that they "may differ slightly from those on our packaging and distributor websites" (7 Nov 2026) | None (7 Nov 2026) | 90 days on the landing page and on a second system page, both requiring before-and-after photos taken after each 2-week treatment within the 90 days (7 Nov 2026); a bundle product page, the refund policy and the returns page state 30 days; the refund policy now deducts "$10 + the shipping cost" from a refund and the returns page a $10 restocking fee (7 Nov 2026). On 2 Oct 2026 the refund policy deducted approximately $29 to $49 | Qure Skincare Pty Ltd, named inside the SMS terms clause (7 Nov 2026); the main terms name "Qure Skincare" as the operator (7 Nov 2026) | "4.8 (1,634)" beside a Trustpilot label on the landing page, "4.8/5 Rated by 10k+ Customers" on a one-month bundle page and "4829 Reviews" on a three-month bundle page (7 Nov 2026); landing-page blocks showing "227 Reviews", "249 Reviews", "112 Reviews" and "4662 Reviews" (23 Sep 2026) were not visible in our 2 Oct or 7 Nov 2026 reads | "#1 Derm Rated" and "Original Micro-Infusion" in the page title; "50+ Board Certified Dermatologists recommend" given as the basis; a footnote reads "Based on a user study of 30 participants aged 25-65"; the 31-subject safety-in-use evaluation described on 23 Sep 2026 and not found on 2 Oct 2026 is on the landing page again (7 Nov 2026) |
| Rewind Glow | Not published (7 Nov 2026) | Not published (7 Nov 2026) | User-filled: fill the device with a serum, then attach the head (7 Nov 2026) | An ingredient section lists eight entries (7 Nov 2026) | None (7 Nov 2026) | 30 days, stated in a header badge (7 Nov 2026) | The terms name only "RewindGlow" as the website operator; no legal entity suffix, street address or registration number found (7 Nov 2026) | "39,600+ Have Switched to Rewindglow" (7 Nov 2026); "1,382 reviews" on the system (7 Nov 2026) | "best-selling" wording; no number-one, FDA or dermatologist claims in our read (7 Nov 2026) |
| Seranova | Not on the product page (7 Nov 2026); the page stated 0.5 mm in July 2026; an Amazon listing title says 0.05 mm | No method named; heads described as sterile and single-use in the page FAQ (7 Nov 2026); no sterile wording was found on 2 Sep 2026; heads were called sterile in brand copy (28 Jul 2026) | User opens the device and fills it (7 Nov 2026) | Published in full (7 Nov 2026) | None (7 Nov 2026) | 90 days from the date of the first Seranova order, for the first order only and one claim per customer, excluding shipping; the guarantee page asks only that the product be used "as directed" (7 Nov 2026). The condition read on 2 Oct 2026, consistent use documented with monthly photos, was not found on the product page, the guarantee page or the refund policy (7 Nov 2026); no photo condition was stated on 2 Sep 2026 | Valentine Brands LLC, named in the terms as owner and maintainer of the website, with a Wilmington, Delaware suite address for its copyright agent and a 701 Tillery Street, Austin, Texas address for its legal department (7 Nov 2026); a Wilmington, Delaware suite address was recorded on 28 Jul 2026; its BBB file carried 263 complaints in the twelve months to August 2026 (23 Aug 2026) | 4.8, "9603 reviews" on the product page (7 Nov 2026), up from "8,645 reviews" (2 Oct 2026) and "8,469 reviews" (23 Sep 2026); a Trustpilot block reading "Based on 2,181 reviews" (2 Oct 2026) was not visible in our 7 Nov 2026 read | "The Original Micro Infusion System" in the site title (7 Nov 2026); "Dermatologist Reviewed", "Dermatologist Tested" and a "Tested by Dermatest" badge, with 2025 Marie Claire UK and Tatler Beauty Awards wins cited (7 Nov 2026); "Recommended by Dermatologists", footnoted "Dermatologists featured are compensated for the use of their name and likeness." (7 Nov 2026); vegan and cruelty-free badges (7 Nov 2026) |
Observations the ledger surfaces
- Two brands describe themselves as the original. Qure's product page title includes "Original Micro-Infusion" and Seranova's site title reads "The Original Micro Infusion System", both re-read on 7 November 2026. At most one of these can be accurate. The ledger takes no position on which; it records the words.
- Sterilisation method is the rarest disclosure. Of the ten, only EvenSkyn (gamma) and Qure (ethylene oxide) name the method their needles were sterilised with. Several others use the words sterile or sterilized without saying how.
- Published depth figures move. Glov's main product page stated 0.25 mm on 31 August 2026 where two pages had stated 0.5 mm in July; Seranova's product page carried 0.5 mm in July and no figure at the end of August. Needle length is the single most safety-relevant number in this category, which is why the ledger keeps the history rather than only the current value.
- Review counts are not always internally consistent. Glov's page has shown both "9,148 Reviews" and "23.750+ reviews"; Elixa's page now shows "571 Reviews" in one block, "440 reviews" in another (411 on 2 October, 393 on 2 September) and a "12,000+ Happy Customers" line beside them; AMIRO's shows 11. Ours shows 16, at 4.9 out of 5, on a product that launched in 2026.
- On the "FDA Approved" serum label. An AMIRO page tile labeled a companion PDRN serum "FDA Approved" (read 31 August and again on 2 October 2026); the phrase did not appear in our 23 September or 7 November 2026 text reads, and the row keeps all four readings. For context, the FDA's own page on its authority over cosmetics states: "Under the law, cosmetic products and ingredients do not need FDA premarket approval, with the exception of color additives." Readers can weigh the label against that sentence themselves. Our position on regulatory wording for this whole category, including our own products, is set out in the device-category reference.
- PDRN concentration figures are not comparable across brands. AMIRO's 27% describes a freeze-dried microsphere before reconstitution; Alqemi's serum page lists 562,400 PPM; ready-to-use liquids are measured on a different basis. The working through of why these numbers cannot be lined up is on the PDRN evidence page.
- Our own weakest cell is company registration. Dr. Pen's Australian distributor is the only seller in this ledger publishing a registration number. Our terms name EvenSkyn without one. We publish the ledger anyway, because a disclosure table that hid its author's gaps would not deserve to be cited.
Cadence and corrections
The ledger is re-read monthly, and any cell that changes gets the new value, the new date, and, where the change is material, the old value kept alongside. A brand that believes a cell misstates its published material can write to us through the contact page with a link to the page in question; we will re-read it and update the cell against the new date. Corrections change cells, not history: superseded values remain visible where the change matters.
For the comparison-shaped version of this material, with scoring and a verdict, see the micro-infusion buyer's guide and the nine-kit comparison. This page deliberately does neither: it is the evidence layer those pages stand on.
Sources
Every cell was read from the named brand's own public product pages, policy pages, or site titles on the date shown in the cell. The FDA quotation is from FDA Authority Over Cosmetics, read 31 August 2026. No brand was contacted for this ledger, and no brand has endorsed it.
Disclosure: EvenSkyn manufactures the MicroInfuser and maintains this ledger, so its row is written by an interested party held to the ledger's own standard. Statements about competitors are limited to what their pages published on the dates shown, kept so that every entry can be re-checked. This page is not medical advice and makes no safety comparison between products; for device-category and regulatory context see the device-category reference.





